BRPI0818762A2 - Composição de biocamada para a liberação de tramadol e acetaminofeno, uso de uma composição, e, método de tratar um mamífero em necessidade de analgesia - Google Patents
Composição de biocamada para a liberação de tramadol e acetaminofeno, uso de uma composição, e, método de tratar um mamífero em necessidade de analgesiaInfo
- Publication number
- BRPI0818762A2 BRPI0818762A2 BRPI0818762A BRPI0818762A2 BR PI0818762 A2 BRPI0818762 A2 BR PI0818762A2 BR PI0818762 A BRPI0818762 A BR PI0818762A BR PI0818762 A2 BRPI0818762 A2 BR PI0818762A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- biocayer
- tramadol
- analgesia
- acetaminophen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98020307P | 2007-10-16 | 2007-10-16 | |
US60/980203 | 2007-10-16 | ||
PCT/CA2008/001799 WO2009049405A1 (en) | 2007-10-16 | 2008-10-15 | Bilayer composition for the sustained release of acetaminophen and tramadol |
Publications (4)
Publication Number | Publication Date |
---|---|
BRPI0818762A2 true BRPI0818762A2 (pt) | 2015-04-07 |
BRPI0818762A8 BRPI0818762A8 (pt) | 2017-09-19 |
BRPI0818762B1 BRPI0818762B1 (pt) | 2019-07-02 |
BRPI0818762B8 BRPI0818762B8 (pt) | 2021-05-25 |
Family
ID=40566952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0818762A BRPI0818762B8 (pt) | 2007-10-16 | 2008-10-15 | composição farmacêutica bicamada de liberação imediata e controlada contendo tramadol e acetaminofeno, e, uso de uma composição |
Country Status (15)
Country | Link |
---|---|
US (1) | US8895066B2 (pt) |
EP (1) | EP2203166B1 (pt) |
JP (1) | JP5453280B2 (pt) |
KR (1) | KR20100069685A (pt) |
CN (1) | CN101827590A (pt) |
AR (1) | AR068891A1 (pt) |
AU (1) | AU2008314454A1 (pt) |
BR (1) | BRPI0818762B8 (pt) |
CA (1) | CA2678092C (pt) |
CO (1) | CO6270218A2 (pt) |
ES (1) | ES2541809T3 (pt) |
MX (1) | MX336494B (pt) |
RU (1) | RU2469718C2 (pt) |
TW (1) | TW200927196A (pt) |
WO (1) | WO2009049405A1 (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090162431A1 (en) * | 2002-09-21 | 2009-06-25 | Shuyi Zhang | Sustained release formulations containing acetaminophen and tramadol |
CA2720108C (en) | 2008-03-11 | 2016-06-07 | Depomed, Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
US8372432B2 (en) | 2008-03-11 | 2013-02-12 | Depomed, Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
US9198861B2 (en) | 2009-12-22 | 2015-12-01 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
US8597681B2 (en) | 2009-12-22 | 2013-12-03 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
US20120015031A1 (en) | 2010-07-14 | 2012-01-19 | Grunenthal Gmbh | Novel gastro-retentive dosage forms |
CN102670542A (zh) * | 2011-03-17 | 2012-09-19 | 北京天衡药物研究院 | 盐酸曲马多渗透泵控释片 |
US8741885B1 (en) | 2011-05-17 | 2014-06-03 | Mallinckrodt Llc | Gastric retentive extended release pharmaceutical compositions |
US8858963B1 (en) | 2011-05-17 | 2014-10-14 | Mallinckrodt Llc | Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia |
US9050335B1 (en) | 2011-05-17 | 2015-06-09 | Mallinckrodt Llc | Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia |
US10702485B2 (en) | 2011-07-09 | 2020-07-07 | Syntrix Biosystems Inc. | Compositions and methods for overcoming resistance to tramadol |
JP6255474B2 (ja) * | 2013-03-15 | 2017-12-27 | マリンクロッド エルエルシー | 機能的割線を有する即時放出用の乱用抑止性固体剤形 |
DE102013009114A1 (de) | 2013-05-29 | 2014-12-04 | Franz Gerstheimer | Pharmazeutische Zusammensetzung zur Überwindung von Metabolisierungsproblemen |
KR101710792B1 (ko) * | 2015-07-14 | 2017-02-28 | 주식회사 유영제약 | 세레콕시브 및 트라마돌을 함유하는 약제학적 조성물 |
US9980900B2 (en) * | 2015-12-22 | 2018-05-29 | Revogenex Ireland Ltd | Intravenous administration of tramadol |
US9693949B1 (en) * | 2015-12-22 | 2017-07-04 | Revogenex Ireland Ltd | Intravenous administration of tramadol |
CA3034722C (en) * | 2017-10-13 | 2019-07-16 | Altus Formulation Inc. | Starch-based release modifying excipients and pharmaceutical compositions derived therefrom |
GB2567493B (en) * | 2017-10-13 | 2019-12-18 | Altus Formulation Inc | Starch-based release modifying excipients and pharmaceutical compositions derived therefrom |
US11000488B2 (en) | 2019-03-22 | 2021-05-11 | Syntrix Biosystems Inc. | Treating pain using desmetramadol |
DE102021210130A1 (de) * | 2021-09-14 | 2023-03-16 | Robert Bosch Gesellschaft mit beschränkter Haftung | Fluidleitvorrichtung für einen Scheibenwischer |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3652589A (en) | 1967-07-27 | 1972-03-28 | Gruenenthal Chemie | 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols |
US4820522A (en) | 1987-07-27 | 1989-04-11 | Mcneilab, Inc. | Oral sustained release acetaminophen formulation and process |
US5004613A (en) | 1987-07-27 | 1991-04-02 | Mcneil-Ppc, Inc. | Oral sustained release pharmaceutical formulation and process |
US4968509A (en) | 1987-07-27 | 1990-11-06 | Mcneilab, Inc. | Oral sustained release acetaminophen formulation and process |
US5133974A (en) | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
US5603956A (en) | 1990-11-27 | 1997-02-18 | Labopharm Inc. | Cross-linked enzymatically controlled drug release |
CA2041774C (en) | 1990-11-27 | 1994-04-19 | Mircea A. Mateescu | Use of cross-linked amylose as a matrix for the slow release of biologically active compounds |
KR100243956B1 (ko) | 1991-09-06 | 2000-03-02 | 랄프 알. 팔로 | 트라마돌 물질 및 아세트아미노펜을 포함하는 통증 치료용 약제학적 조성물 |
US5478577A (en) | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
US5616343A (en) | 1993-03-25 | 1997-04-01 | Labopharm, Inc. | Cross-linked amylose as a binder/disintegrant in tablets |
NZ260408A (en) | 1993-05-10 | 1996-05-28 | Euro Celtique Sa | Controlled release preparation comprising tramadol |
IL110014A (en) | 1993-07-01 | 1999-11-30 | Euro Celtique Sa | Solid controlled-release oral dosage forms of opioid analgesics |
IT1264696B1 (it) | 1993-07-09 | 1996-10-04 | Applied Pharma Res | Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata |
DE4329794C2 (de) | 1993-09-03 | 1997-09-18 | Gruenenthal Gmbh | Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung |
US6210714B1 (en) | 1993-11-23 | 2001-04-03 | Euro-Celtique S.A. | Immediate release tablet cores of acetaminophen having sustained-release coating |
GB9519363D0 (en) | 1995-09-22 | 1995-11-22 | Euro Celtique Sa | Pharmaceutical formulation |
AUPN605795A0 (en) | 1995-10-19 | 1995-11-09 | F.H. Faulding & Co. Limited | Analgesic pharmaceutical composition |
US5773031A (en) | 1996-02-27 | 1998-06-30 | L. Perrigo Company | Acetaminophen sustained-release formulation |
US5807575A (en) | 1997-02-14 | 1998-09-15 | Rougier Inc. | Manufacture of cross-linked amylose useful as a excipient for control release of active compounds |
BE1011045A3 (fr) | 1997-03-14 | 1999-04-06 | Ucb Sa | Compositions pharmaceutiques pour la liberation controlee de substances actives. |
FR2772615B1 (fr) | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
US6284273B1 (en) | 1998-02-24 | 2001-09-04 | Vincent Lenaerts | Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds |
US6245357B1 (en) | 1998-03-06 | 2001-06-12 | Alza Corporation | Extended release dosage form |
US6156342A (en) | 1998-05-26 | 2000-12-05 | Andex Pharmaceuticals, Inc. | Controlled release oral dosage form |
IT1301966B1 (it) * | 1998-07-30 | 2000-07-20 | Zambon Spa | Composizioni farmaceutiche ad attivita' analgesica |
US6245387B1 (en) | 1998-11-03 | 2001-06-12 | Diamon-Fusion International, Inc. | Capped silicone film and method of manufacture thereof |
BR0009437A (pt) | 1999-03-31 | 2002-01-15 | Janssen Pharmaceutica Nv | Amido pré-gelatinizado em uma formulação de liberação controlada |
AU2276801A (en) | 1999-12-20 | 2001-07-03 | Schering Corporation | Extended release oral dosage composition |
US6761895B2 (en) | 2000-04-17 | 2004-07-13 | Yamanouchi Pharmaceutical Co., Ltd. | Drug delivery system for averting pharmacokinetic drug interaction and method thereof |
GB0009522D0 (en) | 2000-04-19 | 2000-06-07 | Smithkline Beecham Plc | Composition |
US6955821B2 (en) | 2000-04-28 | 2005-10-18 | Adams Laboratories, Inc. | Sustained release formulations of guaifenesin and additional drug ingredients |
US6607748B1 (en) * | 2000-06-29 | 2003-08-19 | Vincent Lenaerts | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
CA2423558A1 (en) | 2000-10-03 | 2002-04-11 | Penwest Pharmaceuticals Company | Delivery system for multi-pharmaceutical active materials at various release rates |
US20020106408A1 (en) * | 2000-12-01 | 2002-08-08 | Johnatan Bacon | Prolamin-based sustained-release compositions and delayed-onset compositions |
US6968551B2 (en) | 2001-06-11 | 2005-11-22 | John Hediger | System and user interface for generation and processing of software application installation instructions |
US20030092724A1 (en) | 2001-09-18 | 2003-05-15 | Huaihung Kao | Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic |
US8329217B2 (en) * | 2001-11-06 | 2012-12-11 | Osmotica Kereskedelmi Es Szolgaltato Kft | Dual controlled release dosage form |
KR100522239B1 (ko) | 2002-07-16 | 2005-10-18 | 주식회사 서울제약 | 아세트아미노펜을 함유하는 제어방출성의 경구용 제제 |
EP1555022B1 (en) * | 2002-09-21 | 2008-02-20 | Shuyi Zhang | Sustained release formulation of acetaminophen and tramadol |
TWI319713B (en) | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
US8487002B2 (en) | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
CA2503361C (en) | 2002-10-25 | 2012-02-28 | Labopharm Inc. | Controlled-release compositions |
CA2419349A1 (en) * | 2003-02-20 | 2004-08-20 | Geoffrey Lambert | A modular display holder for a card |
JP4919801B2 (ja) | 2003-09-26 | 2012-04-18 | アルザ・コーポレーシヨン | 高い薬剤配合量を提供する薬剤コーティング及びそれを提供する方法 |
US20080031901A1 (en) | 2004-09-24 | 2008-02-07 | Abbott Laboratories | Sustained release monoeximic formulations of opioid and nonopioid analgesics |
US20060172006A1 (en) * | 2003-10-10 | 2006-08-03 | Vincent Lenaerts | Sustained-release tramadol formulations with 24-hour clinical efficacy |
US20050157382A1 (en) | 2004-01-07 | 2005-07-21 | Kafka James D. | Industrial directly diode-pumped ultrafast amplifier system |
US7622137B2 (en) * | 2004-05-21 | 2009-11-24 | Accu-Break Technologies, Inc. | Dosage forms contained within a capsule or sachet |
US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
US20060257473A1 (en) | 2005-05-11 | 2006-11-16 | Porranee Puranajoti | Extended release tablet |
EP2402005B1 (en) | 2005-08-24 | 2020-12-16 | Endo Pharmaceuticals Inc. | Sustained release formulations of nalbuphine |
CA2616204C (en) | 2005-09-09 | 2015-12-01 | Labopharm Inc. | Sustained drug release composition |
EA020867B1 (ru) * | 2006-03-06 | 2015-02-27 | Поузен Инк. | Лекарственные формы для введения комбинаций лекарственных средств |
US20070237816A1 (en) | 2006-04-06 | 2007-10-11 | David Finkelstein | Acetaminophen formulation for joint pain relief |
-
2008
- 2008-10-15 MX MX2010004236A patent/MX336494B/es unknown
- 2008-10-15 WO PCT/CA2008/001799 patent/WO2009049405A1/en active Application Filing
- 2008-10-15 AU AU2008314454A patent/AU2008314454A1/en not_active Abandoned
- 2008-10-15 JP JP2010529201A patent/JP5453280B2/ja active Active
- 2008-10-15 EP EP20080839570 patent/EP2203166B1/en active Active
- 2008-10-15 CN CN200880112295A patent/CN101827590A/zh active Pending
- 2008-10-15 ES ES08839570.2T patent/ES2541809T3/es active Active
- 2008-10-15 US US12/252,117 patent/US8895066B2/en active Active
- 2008-10-15 RU RU2010119463/15A patent/RU2469718C2/ru not_active IP Right Cessation
- 2008-10-15 BR BRPI0818762A patent/BRPI0818762B8/pt active IP Right Grant
- 2008-10-15 CA CA2678092A patent/CA2678092C/en active Active
- 2008-10-15 KR KR1020107008205A patent/KR20100069685A/ko not_active Application Discontinuation
- 2008-10-16 TW TW097139684A patent/TW200927196A/zh unknown
- 2008-10-16 AR ARP080104506A patent/AR068891A1/es not_active Application Discontinuation
-
2010
- 2010-04-16 CO CO10044379A patent/CO6270218A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CO6270218A2 (es) | 2011-04-20 |
TW200927196A (en) | 2009-07-01 |
EP2203166A1 (en) | 2010-07-07 |
EP2203166B1 (en) | 2015-05-06 |
US8895066B2 (en) | 2014-11-25 |
KR20100069685A (ko) | 2010-06-24 |
ES2541809T3 (es) | 2015-07-24 |
CA2678092A1 (en) | 2009-04-23 |
BRPI0818762B8 (pt) | 2021-05-25 |
RU2010119463A (ru) | 2011-11-27 |
WO2009049405A1 (en) | 2009-04-23 |
JP5453280B2 (ja) | 2014-03-26 |
AR068891A1 (es) | 2009-12-16 |
BRPI0818762A8 (pt) | 2017-09-19 |
RU2469718C2 (ru) | 2012-12-20 |
AU2008314454A1 (en) | 2009-04-23 |
CA2678092C (en) | 2013-07-30 |
CN101827590A (zh) | 2010-09-08 |
MX2010004236A (es) | 2010-09-07 |
JP2011500607A (ja) | 2011-01-06 |
BRPI0818762B1 (pt) | 2019-07-02 |
EP2203166A4 (en) | 2012-07-04 |
MX336494B (es) | 2016-01-21 |
US20090130183A1 (en) | 2009-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0818762A2 (pt) | Composição de biocamada para a liberação de tramadol e acetaminofeno, uso de uma composição, e, método de tratar um mamífero em necessidade de analgesia | |
BRPI0814611A2 (pt) | Composição, processo para preparar uma composição, e, uso de uma composição | |
BRPI0807220B1 (pt) | composição, e, métodos para aumentar a força de compressão de uma composição e para aumentar a retenção de fragrância de uma composição | |
BRPI0809655A2 (pt) | Método para tratar uma condição em um mamífero, composição farmacêutica, e, kit | |
BRPI0920955A2 (pt) | processo para a preparação de uma composição polimérica , composição polimérica, misturas, e, uso da composição polimérica | |
BRPI0918487A2 (pt) | processo para a preparação de uma composição de copolímero, composição, e, uso de uma composição de copolímero | |
BRPI0911297A2 (pt) | composição e métodos para preparo e uso das mesmas | |
BRPI0822104A2 (pt) | Composições antimicrobianas e métodos para o uso das mesmas | |
BRPI0811635A2 (pt) | Compostos de arilazol-2-il cianoetilamino, métodos para fazê-los e métodos para o uso dos mesmos | |
BRPI0916630A2 (pt) | composições para uso em construção e processo de aplicação das mesmas | |
BRPI0822972A2 (pt) | "método e aparelho para redução de atrito" | |
BRPI0813201A2 (pt) | "composição curável, compósito e método para formar um compósito" | |
BRPI0913710A2 (pt) | "artigo e métodos para preparação do artigo" | |
BRPI0814157A2 (pt) | Composição de catalisador e processos para a preparação e uma composição de catalisador e para desalquilação de etil-benzeno | |
BRPI0912384A2 (pt) | composição, e, método para preparar uma composição | |
BRPI0808163A2 (pt) | Composição para aplicação tópica, métodos para tratar uma condição de superfície em um indivíduo, para preparar uma composição, e para usar o kit, e, kit | |
BRPI0923384A2 (pt) | composto, composição farmacêutica, e, métodos para tratar um mamífero, e para inibir quimiotaxia celular | |
BRPI0718118A2 (pt) | composições e métodos para ligação de sphingosine-1-fosfato | |
BRPI0812647A2 (pt) | "composição e método para produzir a composição" | |
BRPI0921399A2 (pt) | composição de graxa lubrificante, processo para preparar composição lubrificante, e, uso de uma composição de graxa lubrificante | |
BRPI0909885A2 (pt) | composição decorativa e método para sua utilização | |
BRPI0810525A2 (pt) | Composições e métodos para a profilaxia e tratamento de dependência química | |
BRPI0920383A2 (pt) | método para minimizar o diâmetro de uma solução de uréia, solução de uréia e uso de um tensoativo em solução de uréia | |
BRPI0814477A2 (pt) | "dispositivo e método para backup de objetos de direitos" | |
BR112012013247A2 (pt) | conjunto submarino e método para uso em operações submarinas" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: LABOPHARM EUROPE LIMITED (IE) , LABOPHARM (BARBADO |
|
B25D | Requested change of name of applicant approved |
Owner name: LABOPHARM EUROPE LIMITED (IE) , LABOPHARM (BARBADOS) LIMITED (BB) , LABOPHARM INC. (CA) Owner name: LABOPHARM EUROPE LIMITED (IE) , LABOPHARM (BARBADO |
|
B25A | Requested transfer of rights approved |
Owner name: LABOPHARM EUROPE LIMITED (IE) , LABOPHARM (BARBADO |
|
B25D | Requested change of name of applicant approved |
Owner name: LABOPHARM (BARBADOS) LIMITED (BB) , PALADIN LABS I |
|
B25G | Requested change of headquarter approved |
Owner name: PALADIN LABS INC. (CA) , PALADIN LABS EUROPE LIMIT |
|
B25A | Requested transfer of rights approved |
Owner name: PALADIN LABS INC. (CA) , PALADIN LABS EUROPE LIMIT |
|
B25D | Requested change of name of applicant approved |
Owner name: PALADIN LABS INC. (CA) , PALADIN LABS EUROPE LIMIT |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/07/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/07/2019, OBSERVADAS AS CONDICOES LEGAIS |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/10/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B15V | Prolongation of time limit allowed |